We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treating Acute MI Patients With Aggrastat on Their Way to Hospital

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by The Baruch Padeh Medical Center, Poriya.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00300833
First Posted: March 10, 2006
Last Update Posted: August 11, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
The Baruch Padeh Medical Center, Poriya
  Purpose
Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

Condition Intervention Phase
Acute Myocardial Infarction Drug: Tirofiban Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by The Baruch Padeh Medical Center, Poriya:

Primary Outcome Measures:
  • mortality [ Time Frame: immidiately ]

Secondary Outcome Measures:
  • TIMI flow [ Time Frame: 24 hours ]
    feeling better


Estimated Enrollment: 200
Study Start Date: January 2006
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Tirofiban
    pci
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital

Exclusion Criteria:

  • women less than 50 years old and 80 years old, bleeding tendency, stroke in the past
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00300833


Contacts
Contact: Yonathan Hasin, Professor 97246652648 yhasin@poria.health.gov.il

Locations
Israel
Cardiovascular Division, The Baruch Padeh Medical Center, Poriya, Recruiting
Tiberias, Israel, 15208
Magen David , Recruiting
Tiberias, Israel
Contact: Sergay Krablikov, Dr         
Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Investigators
Study Chair: Menachem Naheer The Baruch Padeh Medicel Center, Poriya, Tiberias, Israel
  More Information

Responsible Party: Menachem Nahir, The baruch Padeh Medical center
ClinicalTrials.gov Identifier: NCT00300833     History of Changes
Other Study ID Numbers: Aggrastat in AMI.CTIL
First Submitted: March 1, 2006
First Posted: March 10, 2006
Last Update Posted: August 11, 2011
Last Verified: January 2009

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Tirofiban
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Platelet Aggregation Inhibitors